GT Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GT Biopharma, Inc. has filed 870 SEC EDGAR filings since 12 May 1995

SEC filing history

Showing 26-50 of 136 matching filings.

Per page
25
Current page
2
8-K/A File 001-40023

8-K/A filing

Filing date
17 Aug 2022
Reporting date
08 Jun 2022
Next action
Verify source filing
8-K File 001-40023

PRIMARY DOCUMENT

Filing date
23 Dec 2021
Reporting date
22 Dec 2021
Next action
Verify source filing
8-K File 001-40023

PRIMARY DOCUMENT

Filing date
21 Dec 2021
Reporting date
15 Dec 2021
Next action
Verify source filing
8-K File 001-40023

PRIMARY DOCUMENT

Filing date
26 Nov 2021
Reporting date
23 Nov 2021
Next action
Verify source filing
8-K File 001-40023

PRIMARY DOCUMENT

Filing date
01 Nov 2021
Reporting date
01 Nov 2021
Next action
Verify source filing
8-K File 001-40023

CURRENT REPORT

Filing date
23 Sep 2021
Reporting date
17 Sep 2021
Next action
Verify source filing
8-K File 001-40023

CURRENT REPORT

Filing date
13 Sep 2021
Reporting date
13 Sep 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .